January 28, 2021
Chugai Pharmaceutical has withdrawn its lawsuit against three Japanese generic makers over the substance patent of its osteoporosis treatment Edirol (eldecalcitol), the defendant companies said in separate statements on January 27. The three companies - Sawai Pharmaceutical, Nichi-Iko Pharmaceutical, and...read more